Here, we discovered that Sema6d deficiency suppressed tumor progression via increased cytotoxic CD8+ T cell infiltration into tumors in a murine oral cancer model using MOC2 cells without endogenous Sema6d expression. This evidence concerns the gene CD8A and lip and oral cavity carcinoma.